Literature DB >> 1575733

Downstream region of the human tyrosinase-related protein gene enhances its promoter activity.

K Shibata1, K Takeda, Y Tomita, H Tagami, S Shibahara.   

Abstract

We have cloned and sequenced the human genomic DNA segments encoding the 5'-flanking region and the first two exons of the tyrosinase-related protein (TRP) gene, a pigment cell-specific gene. Functional analysis of its promoter suggests that the downstream region of the TRP gene, including the first intron, enhances the transient expression of the luciferase gene under control of the TRP gene promoter about 16- to 20-fold. This enhancer-like activity is detected not only in melanoma cells but also in HeLa cells whose TRP gene expression is assumed to be repressed. We suggest a possibility that the downstream region is not sufficient to confer pigment cell-specific expression, but is required for efficient transcription of the TRP gene in pigment cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575733     DOI: 10.1016/0006-291x(92)90627-w

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Complete sequence and polymorphism study of the human TYRP1 gene encoding tyrosinase-related protein 1.

Authors:  N F Box; J R Wyeth; C J Mayne; L E O'Gorman; N G Martin; R A Sturm
Journal:  Mamm Genome       Date:  1998-01       Impact factor: 2.957

2.  Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene.

Authors:  K Yasumoto; K Yokoyama; K Shibata; Y Tomita; S Shibahara
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

3.  Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF.

Authors:  Dong Fang; Yoshiaki Tsuji; Vijayasaradhi Setaluri
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

4.  Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.

Authors:  Jose Pulido; Timothy Kottke; Jill Thompson; Feorillo Galivo; Phonphimon Wongthida; Rosa Maria Diaz; Diana Rommelfanger; Elizabeth Ilett; Larry Pease; Hardev Pandha; Kevin Harrington; Peter Selby; Alan Melcher; Richard Vile
Journal:  Nat Biotechnol       Date:  2012-03-18       Impact factor: 54.908

5.  Immunogenicity of self tumor associated proteins is enhanced through protein truncation.

Authors:  Tim Kottke; Kevin G Shim; Vanesa Alonso-Camino; Shane Zaidi; Rosa Maria Diaz; Jose Pulido; Jill Thompson; Karishma R Rajani; Laura Evgin; Elizabeth Ilett; Hardev Pandha; Kevin Harrington; Peter Selby; Alan Melcher; Richard Vile
Journal:  Mol Ther Oncolytics       Date:  2016-12-07       Impact factor: 7.200

6.  The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site.

Authors:  Vanesa Alonso-Camino; Karishma Rajani; Timothy Kottke; Diana Rommelfanger-Konkol; Shane Zaidi; Jill Thompson; Jose Pulido; Elizabeth Ilett; Oliver Donnelly; Peter Selby; Hardev Pandha; Alan Melcher; Kevin Harrington; Rosa Maria Diaz; Richard Vile
Journal:  Mol Ther       Date:  2014-07-25       Impact factor: 11.454

7.  Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.

Authors:  D Schadendorf; I Fichtner; A Makki; S Alijagic; M Küpper; U Mrowietz; B M Henz
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.